 Oral contraceptive-associated liver cell adenoma hepatocellular carcinoma Cytomorphology mechanism malignant transformation January May patients liver mass masses techniques underwent percutaneous fine-needle aspiration biopsy liver hepatocellular carcinoma consistent liver cell adenoma cytologic diagnoses follow-up cases patients hepatocellular carcinoma oral contraceptives period years patients liver cell adenoma users oral contraceptives period years oral contraceptives period years areas liver cell dysplasia adenomas cytologic criteria diagnosis liver cell dysplasia cytoplasmic nuclear enlargement nuclear pleomorphism prominent nucleoli hyperchromasia multinucleation cytologic features liver cell dysplasia mimic hepatocellular carcinoma study foci areas liver cell dysplasia liver cell link responsible transformation liver cell adenoma liver cell adenomas premalignant reversible change withdrawal causative agents whereas cell dysplasia irreversible premalignant change hepatocellular carcinoma